Prurigo Nodularis
Prurigo nodularis is a skin condition that causes itchy, raised nodules on the skin, often leading to intense scratching and discomfort. It can be triggered by various factors, including allergies and skin irritations.
Prurigo Nodularis: Povorcitinib Treatment Study
We are studying the effects of povorcitinib on itching and skin lesions in people with prurigo nodularis. The goal is to see if it improves symptoms and quality of life while ensuring safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have prurigo nodularis (PN) diagnosed for at least 3 months?
- Have you had an average itch score of 7 or higher in the past week?
- Are you pregnant, considering pregnancy, or breastfeeding?
- Have you had any major surgery in the last 30 days?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Povorcitinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Graz
Medical University of Graz, Dpt. Dermatology and Venerology
Graz, Austria
Klinik Hietzing
Wiener Krankenanstaltenverbund, Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhuegel
Perchtoldsdorf, Austria
Medical Center Medconsult Pleven OOD
Lovech, Bulgaria
Sponsor: Incyte Corp.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.